Back to search
Onchocerciasis, Ocular
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Onchocerciasis, Ocular trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Onchocerciasis, Ocular trials you may qualify forThis study will investigate the safety and effectiveness of combination regimens in persons with onchocerciasis when it is administered after pre-treatment with…
This study aims at evaluating the safety and efficacy of Moxidectin 2 mg in patients with low intensities of microfilariae of Loa loa.
Onchocerciasis or river blindness is an infectious disease caused by a parasitic worm. It spreads through the bite of an infected blackfly. Common symptoms incl…
Onchocerciasis is a major public health problem in affected countries that causes disease-induced disability, and overall loss of economic productivity. The pur…
The trial evaluates safety, tolerability, pharmacodynamics, pharmacokinetics, dose-response, and efficacy of emodepside tablets, administrated as a range of dos…
The primary purpose of this study was to determine the safety and tolerability of moxidectin in subjects infected with Onchocerca volvulus (a parasitic worm).
This study aims at evaluating the safety and efficacy of levamisole in patients with loiasis infection.
The DOLF Ocular Changes after Ivermectin study will investigate the kinetics of O. volvulus microfilaria (Mf) in the eye following treatment with ivermectin. Th…
This is a Phase 3 study comparing the efficacy, safety and tolerability of moxidectin and ivermectin in subjects infected with Onchocerca volvulus, which is the…
The purpose of this study is to measure the amount of moxidectin in subjects' blood and to measure safety. This study will enroll 36 children aged 4 to 11 years…